688677 Qingdao Novelbeam Technology
- 42.85
- +0.74+1.76%
Qingdao Novelbeam Technology News
Institutional Owners May Take Dramatic Actions as Qingdao NovelBeam Technology Co.,Ltd.'s (SHSE:688677) Recent 7.0% Drop Adds to One-year Losses
Key Insights Significantly high institutional ownership implies Qingdao NovelBeam TechnologyLtd's stock price is sensitive to their trading actions 51% of the business is held by the top 6 sharehold
Haitai Xinguang (688677.SH): US customer's hysteroscope mass production plan has been issued and is expected to be officially launched in North America in July
Gelonghui, May 21丨Haitai Xinguang (688677.SH) disclosed an investor relations activity record sheet showing that the US customer's hysteroscope mass production plan has been issued, and the company has already begun production preparations. It is expected to be officially listed in North America in July, and customers are expected to follow up orders based on sales conditions. Customer feedback is that the next-generation camera system works very well with the hysteroscope developed by the company, and they are confident in opening up the gynecology and urology markets. In addition, sample orders have also been placed for cystoscopes, and the product will be officially released after passing the tests. The company's own brands of hysteroscopes and cystoscopes are also in the registration process, and it is expected that registration will be completed this year
Haitai Xinguang (688677.SH): The subsidiary in Nevada, USA is currently being reviewed by US customers
Gelonghui, May 21丨Haitai Xinguang (688677.SH) disclosed an investor relations activity record sheet showing that its subsidiary in Nevada in the US is currently being reviewed by US customers, and can directly accept endoscope orders from US customers after approval. At the same time, the subsidiary established by the company in Thailand has completed plant renovation, and the first batch of production equipment has also been sent to the Thai factory. The plan is to establish production capacity by the end of June and submit it to the customer for review. The establishment of overseas subsidiaries helps the company optimize the international supply chain, while also reducing the possible impact of tariffs to a certain extent.
Haitai Xinguang (688677.SH): This week, the US announced that it will increase import tariffs on some Chinese medical products. This does not include products exported by the company
Gelonghui, May 17丨Haitai Xinguang (688677.SH) said on the investor interactive platform that this week the US announced that it would increase import tariffs on some Chinese medical products, which did not involve products exported by the company, and had no impact on the company. The main purpose of establishing the Thai factory is to optimize the supply chain in overseas markets, while also reducing the possible impact of tariffs.
Gelonghui Announcements Selected | Duoli Technology: Plans to invest 900 million yuan to build an intelligent manufacturing base project for Lingang Daya auto parts; Societe Generale Co., Ltd.: Sales of impregnated resin for C919 brake pads for large dome
[Hot Focus] Qianjiang Biochemical (600796.SH): Currently, Qianjiang Biochemical (600796.SH), which does not involve synthetic biologics-related products and businesses, announced that some media have incorporated the company into the concept of “synthetic biology.” The company's main business is ecological and environmental protection, biological pesticides, and water services. Among them, the biopesticide business achieved operating revenue of 311 million yuan in 2023, accounting for about 15.30% of total revenue, which is relatively small. The company currently does not involve products or businesses related to synthetic organisms, so it is not involved in the concept of “synthetic biology”. The media paid attention to the company's establishment of Molecular Life
Haitai Xinguang (688677.SH): Plans to buy back shares for 26 million yuan to 50 million yuan
Gelonghui, May 8, 丨 Haitai Xinguang (688677.SH) announced that the company plans to repurchase the company's shares for 26 million yuan to 50 million yuan, at a repurchase price of no more than 69 yuan/share.
Haitai Xinguang (688677.SH) plans to spend 26 million yuan to 50 million yuan to implement a repurchase
Zhitong Finance App News, Haitai Xinguang (688677.SH) announced that the company plans to repurchase shares through centralized bidding, with a total repurchase capital of not less than 26 million yuan (inclusive) and no more than 50 million yuan (inclusive); the repurchase price of shares shall not exceed 69 yuan/share (inclusive). The share repurchase period is 12 months from the date the board of directors reviewed and approved the repurchase plan.
Haitai Xinguang (688677.SH) reported first-quarter results, net profit of 384.427 million yuan, a year-on-year decrease of 20.68%
Haitai Xinguang (688677.SH) released its report for the first quarter of 2024, achieving revenue of 118 million yuan...
Qingdao NovelBeam Technology Co.,Ltd. (SHSE:688677) Stocks Pounded By 27% But Not Lagging Market On Growth Or Pricing
Qingdao NovelBeam Technology Co.,Ltd. (SHSE:688677) shares have had a horrible month, losing 27% after a relatively good period beforehand. The drop over the last 30 days has capped off a tough yea
Qingdao NovelBeam TechnologyLtd's (SHSE:688677) Returns On Capital Not Reflecting Well On The Business
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Typically, we'll want to notice a trend of growing return on
Haitai Xinguang (688677.SH): A total cost of 46.17 million yuan to buy back 0.7325% of the shares
Gelonghui, April 1, 丨 Haitai Xinguang (688677.SH) announced that by the end of March 2024, the company had repurchased a total of 890,948 shares, accounting for 0.7325% of the company's total share capital. The highest purchase price was 60.36 yuan/share, the lowest price was 44.88 yuan/share, and the total amount paid was 46,172,168.34 yuan (excluding transaction fees such as stamp duty and transaction commissions).
Guotai Junan: The medical device procurement side is expected to improve season by season, and the boom has quietly arrived
The medical device procurement side is expected to improve quarter by season, and the boom has quietly arrived.
Qingdao NovelBeam Technology Co.,Ltd. (SHSE:688677) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
With its stock down 10% over the past three months, it is easy to disregard Qingdao NovelBeam TechnologyLtd (SHSE:688677). However, a closer look at its sound financials might cause you to think aga
Haitai Xinguang (688677.SH): A total of 899,900 shares have been repurchased
Gelonghui, March 1, 丨 Haitai Xinguang (688677.SH) announced that by the end of February 2024, the company had repurchased a total of 890,948 shares, accounting for 0.7325% of the company's total share capital. The highest purchase price was 60.36 yuan/share, the lowest price was 44.88 yuan/share, and the total amount paid was 46,172,168.34 yuan (excluding transaction fees such as stamp duty and transaction commissions).
Haitai Xinguang (688677.SH) performance report: 2023 net profit of 146 million yuan fell 20.07% year on year
Gelonghui, Feb. 23 | Haitai Xinguang (688677.SH) announced its 2023 annual performance report. During the reporting period, the company achieved total operating revenue of 471 million yuan, a year-on-year decrease of 1.31%; realized net profit attributable to owners of the parent company of 146 million yuan, a year-on-year decrease of 20.07%; realized net profit attributable to owners of the parent company after deducting non-recurring gains and losses of 137 million yuan, a year-on-year decrease of 19.07%.
Haitai Xinguang (688677.SH): The ban on 46.438 million restricted shares was lifted on February 26
Gelonghui, Feb. 19: Haitai Xinguang (688677.SH) announced that the total number of shares in circulation in the company's current stock listing is 46.438 million shares. The stock listing and circulation date is February 26, 2024.
Haitai Xinguang (688677.SH): By the end of January, 889,900 shares had been repurchased
Gelonghui, February 1, 丨 Haitai Xinguang (688677.SH) announced that by the end of January 2024, the company had repurchased a total of 880,948 shares, accounting for 0.7242% of the company's total share capital. The highest purchase price was 60.36 yuan/share, the lowest price was 44.88 yuan/share, and the total amount paid was 45,658,486.94 yuan (excluding transaction fees such as stamp duty and transaction commissions).
In the Wake of Qingdao NovelBeam Technology Co.,Ltd.'s (SHSE:688677) Latest CN¥367m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions
Key Insights Significantly high institutional ownership implies Qingdao NovelBeam TechnologyLtd's stock price is sensitive to their trading actions 50% of the business is held by the top 10 sharehol
Haitai Xinguang (688677.SH): Has repurchased a total of 723,500 shares
Gelonghui, January 2, 丨 Haitai Xinguang (688677.SH) announced that by the end of December 2023, the company had repurchased a total of 7234.52 million shares, accounting for 0.5948% of the company's total share capital. The highest purchase price was 60.36 yuan/share, the lowest price was 48.39 yuan/share, and the total amount paid was 38,353,793.37 yuan (excluding transaction fees such as stamp duty and transaction commissions).
Haitai Xinguang (688677.SH): The company's newly registered light source is a supporting second-generation complete machine system, and marketing and sales have begun
Gelonghui, December 14|Haitai Xinguang (688677.SH) disclosed the investor relations activity record sheet, because all components of the machine, including the laparoscope, light source, and camera system, are registered separately and used together. The company's newly registered light source is used to support the second-generation complete machine system, and marketing and sales have already begun.
Analysis
Price Target
No Data
